The Business Research Company’s report on the Pet Diabetes Care Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the primary drivers fueling the growth of the pet diabetes care market in recent years?
An increase in pet adoption is expected to propel the growth of the pet diabetes care market going forward. Pet adoption is the process of obtaining a pet from a shelter or rescue that has been left behind by its prior owners, as opposed to buying a pet from a pet store, breeder, or other individuals. Diabetes is increasingly being diagnosed in pets every year, which is partly because their lifestyles mirror ours in that they are more sedentary and rely more heavily on processed foods. For example, in 2022, Animal Medicines Australia, a non-governmental organization based in Australia, reported significant growth in pet ownership, with the number of pet owners reaching 28,730.8 in 2022, up from 39% in 2021. This marks a 24% increase, reflecting a strong upward trend in pet adoption and investment in care. The surge in pet ownership highlights the increasing popularity of pets in Australian households. Therefore, an increase in pet adoption is driving the growth of the pet diabetes care market.
Access Your Free Sample of the Global Pet Diabetes Care Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp
What is the projected market size of the pet diabetes care industry, and how is it expected to grow?
The pet diabetes care market size has grown strongly in recent years. It will grow from $2.21 billion in 2024 to $2.41 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to growing awareness of pet health, advancements in veterinary medicine, prevalence of diabetes in pets, humanization of pets, increased focus on pet nutrition, awareness campaigns by veterinary organizations, availability of insulin and medications.
The pet diabetes care market size is expected to see strong growth in the next few years. It will grow to $3.49 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rise in pet insurance adoption, customized diabetes management plans, focus on preventive pet healthcare, globalization of pet health trends, increasing investments in pet healthcare research, rising consumer affluence. Major trends in the forecast period include advancements in veterinary diagnostics, focus on pet obesity management, innovation in insulin delivery systems, rise in pet insurance coverage, increased availability of specialized pet foods:, telemedicine and remote monitoring, collaborations in veterinary medicine.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8095&type=smp
Who are the key players driving competition in the pet diabetes care market?
Major companies operating in the pet diabetes care market are C.H. Boehringer Sohn AG & Co. KG, Becton Dickinson and Company, Merck & Co Inc., Zoetis Inc., Trividia Health Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc., Henry Schein VET GmbH, Medtrust Holdings Inc., i-SENS Inc., Taidoc Technology Corp., Covetrus Inc., ALR Technologies Inc., Vet Innovations Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Dexcom Inc., LifeScan Inc., Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Senseonics Holdings Inc., Tandem Diabetes Care Inc., Terumo Corporation, Animas Corporation, Insulet Corporation, Roche Diabetes Care Inc.
What key trends are expected to drive the perimeter security market during the forecast period?
Increased research and development activity and the launch of new products are the key trends gaining popularity in the pet diabetes market. Numerous studies are being conducted on diabetes in animals to understand the condition better and make management more effortless. Moreover, companies are launching new products, such as generic drugs, to sustain their position in the market. In December 2022, the U.S. Food and Drug Administration (FDA), a scientific regulatory agency, approved the medication from Elanco Animal Health Inc. for cats with a specific type of diabetes, making it the first oral medication authorized for the condition in animals.
Which key geographies are driving the growth of the pet diabetes care market?
North America was the largest region in the pet diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report
What are the key segments driving growth in the pet diabetes care market?
The pet diabetes care market covered in this report is segmented –
1) By Drug Type: Insulin Therapy, Oral Medication
2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices
3) By Animal Type: Canine, Feline, Other Animal Types
4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals
Subsegments:
1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices
2) By Oral Medication: Glipizide, Metformin, Other Oral Hypoglycemic Agents
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8095
How is the pet diabetes care market defined, and what are its core characteristics?
Pet diabetes care is used to treat pets suffering from diabetes, which may also cause other diseases such as heart disease, pancreatitis, urinary tract infections, kidney disease, and skin infections. Diabetes develops when a pet’s body produces insufficient insulin, stops generating it altogether, or uses it improperly, which hinders the body from converting food into energy.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
